Meal or no meal? how food might alter a new Drug's path
NCT ID NCT06861829
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This early-stage trial in healthy men aged 18 to 50 tests whether eating affects how much of the experimental drug BI 3731579 enters the blood. Each participant receives a single oral dose of the drug once with food and once without, allowing researchers to compare the levels in the body. The goal is to understand if food changes the drug's absorption, which could inform how it is taken in future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BI 3731579
- What this could lead to
- If food affects how the body absorbs this drug, the findings could guide how it should be taken in future studies.
- What could go wrong
- This is an early, small trial in healthy volunteers, so results may not predict effects in patients or reflect real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test